C.H. Robinson Projects $300 Million in Synergies from RXO Acquisition and Pauses Share Repurchases
During the Q3 2026 earnings call, C.H. Robinson (CHRW) management provided updates regarding its strategic acquisition of RXO. CEO David Bozeman expressed confidence in the deal, projecting approximately $300 million in net synergies resulting from the integration of the two companies. To support this transition and prioritize balance sheet health, the company announced a pause in its share repurchase program. This capital reallocation is intended to facilitate deleveraging, with management setting a target to reduce debt levels by the end of 2028.
Topics: corporate strategy earnings call mergers and acquisitions